All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378041%3A_____%2F19%3A00517908" target="_blank" >RIV/68378041:_____/19:00517908 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11110/19:10394483 RIV/00216208:11140/19:10394483

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S1383574219300080?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1383574219300080?via%3Dihub</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.mrrev.2019.05.002" target="_blank" >10.1016/j.mrrev.2019.05.002</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review

  • Original language description

    The development of minimally invasive and low-cost assay enabling early diagnosis, treatment response and prognosis in cancer patients may provide a promising alternative to tumor biopsy. Circulating cell-free DNA (cfDNA) is probably the most promising tool among all components of liquid biopsy. This review includes studies exploring cfDNA as the diagnostic, prognostic or predictive biomarker for all types of cancer. In this article, we systematically reviewed the relevant literature from PubMed about cfDNA. All articles presented higher cfDNA concentration in cancer patients when compared with patients with benign disease or healthy individuals. Most of the articles showed a connection between cfDNA and prognosis. The presence of high cfDNA level in serum or plasma was associated with worse overall patient's survival. This review supports the idea that the cfDNA analysis represents a promising research area and hopefully in the future, could be applied as a new biomarker for cancer detection, prognosis determination and prediction of the response to therapy.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30101 - Human genetics

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Mutation Research-Reviews in Mutation Research

  • ISSN

    1383-5742

  • e-ISSN

  • Volume of the periodical

    781

  • Issue of the periodical within the volume

    jul.-sep.

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    30

  • Pages from-to

    100-129

  • UT code for WoS article

    000482872300008

  • EID of the result in the Scopus database

    2-s2.0-85065765334